Skip to content

A Multicenter Breast Cancer Biospecimen Registry

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02712645
Enrollment
700
Registered
2016-03-18
Start date
2016-02-29
Completion date
Unknown
Last updated
2016-04-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Brief summary

This study is being performed to collect blood for the development of noninvasive tests that can screen for or diagnose cancer. Blood samples will be collected from women who are scheduled to have breast biopsies.

Interventions

None listed

Sponsors

Luminist, Inc.
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
40 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Females of all racial and ethnic groups who are 40 years or older. 2. Women must: 1. have suspected neoplasm of the breast (BIRADS 4 or 5) based on the results of any breast screening or diagnostic imaging, such as mammogram, and 2. be selected or scheduled for a breast biopsy which has not yet been conducted at the time of enrollment.

Exclusion criteria

1. Inability to sign informed consent. 2. More than one radiological finding. 3. Any current or prior cancer (with the exception of non-melanoma skin cancer or a suspected breast malignancy targeted for biopsy). 4. Any known or suspected acute illness or condition - including acute infections - at the time of enrollment or within the previous 30 days. 5. Any surgery, hospitalization, or institutionalization (such as in a nursing home) during the previous 3 months. 6. Received any experimental therapeutic treatment during the previous 3 months. 7. Received any blood product transfusion within the previous 3 months. 8. Use of illegal drugs during the previous 3 months. 9. Pregnant or nursing at the time of enrollment or in the preceding 12 months.

Design outcomes

Primary

MeasureTime frame
Number of patients with untreated newly diagnosed breast cancer.1 Year

Countries

United States

Contacts

Primary ContactStorm Stillman
clinical@luminist.io
Backup ContactWill Olsen

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026